STI | 1999 N = 314 | Prevalence (%) (95%CI) | 2003 N = 385 | Prevalence (%) (95%CI) |
---|
Trichomonas†| 128 | 40.8 (35.3–46.4) | 106 | 27.5 (23.1–32.3) |
Gonorrhoea‡ | 60 | 19.1 (14.9–23.9) | 23 | 6.0 (3.8–8.8) |
Chlamydia* | 53 | 16.9 (12.9–21.5) | 37 | 9.6 (6.9–13.0) |
Syphilis RPR | 76 | 24.2 (19.6–29.3) | 67 | 17.4 (13.5–21.6) |
Syphilis TPHA | 130 | 41.4 (35.0–47.1) | 155 | 40.3 (35.3–45.4) |
 | N = 314 |  | N = 401 |  |
HIV** | 37 | 11.7 (8.4–15.9) | 53 | 13.2 (10.1–16.9) |
- CSWs: commercial sex workers †Wet Mount Microscopy and culture were used on vaginal swab sample ‡ Gram stain, culture in modified Thayer Martin (MTM)/modified New York culture (MNYC) media and antibiotic susceptibility test (and in 1999, PAGE2 as well) were used on endocervical swab sample. * PACE-2 test (and in 1999, Enzyme Immunoassay as well) were used on endocervical sample ** Double Enzyme-Linked ImmunoSorbent Assay (ELISA) test was used on serum sample. RPR: Rapid plasma regain. TPHA: Treponema Pallidum Haemagglutination test.